Literature DB >> 34608468

Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics.

Nem Singh1, Subin Son1, Jusung An1, Ilwha Kim1, Minhyeok Choi1, Na Kong2, Wei Tao2, Jong Seung Kim1.   

Abstract

Finding a personalized nano theranostics solution, a nanomedicine for cancer diagnosis and therapy, is among the top challenges of current medicinal science. Porous organic polymers (POPs) are permanent porous organic materials prepared by linking relatively rigid multidimensional organic building blocks. POP nanoparticles have a remarkable advantage for cancer theranostics owing to their specific physicochemical characteristics such as high surface area, convincing pore size engineering, stimuli-responsive degradability, negligible toxicity, open covalent post-synthesis modification possibilities etc. POPs have crystalline and non-crystalline characteristics; crystalline POPs are popularly known as covalent organic frameworks (COFs), and have shown potential application across research areas in science. The early research and development on theranostics applications of nanoscale POPs has shown tremendous future potential for clinical translation. This tutorial review highlights the recently developed promising applications of nPOPs in drug loading, targeted delivery, endogenous and exogenous stimuli-responsive release, cancer imaging and combination therapy, regardless of their crystalline and poorly crystalline properties. The review will provide a platform for the future development and clinical translation of nPOPs by solving fundamental challenges of cancer nanomedicines in drug loading efficiency, size-optimization, biocompatibility, dispersibility and cell uptake ability.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34608468     DOI: 10.1039/d1cs00559f

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  5 in total

1.  Ambient synthesis of an iminium-linked covalent organic framework for synergetic RNA interference and metabolic therapy of fibrosarcoma.

Authors:  Le-Le Zhou; Qun Guan; Wei Zhou; Jing-Lan Kan; Yu-Bin Dong
Journal:  Chem Sci       Date:  2022-06-15       Impact factor: 9.969

2.  Templated Assembly of pH-Labile Covalent Organic Framework Hierarchical Particles for Intracellular Drug Delivery.

Authors:  Fangzhou Zhou; Yuanyuan Fang; Chao Deng; Qian Zhang; Minying Wu; Hsin-Hui Shen; Yi Tang; Yajun Wang
Journal:  Nanomaterials (Basel)       Date:  2022-09-02       Impact factor: 5.719

Review 3.  Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Authors:  Nem Singh; Jungryun Kim; Jaewon Kim; Kyungwoo Lee; Zehra Zunbul; Injun Lee; Eunji Kim; Sung-Gil Chi; Jong Seung Kim
Journal:  Bioact Mater       Date:  2022-09-14

Review 4.  Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review.

Authors:  Jinsong Zhang; Tianyuan Zhang; Jianqing Gao
Journal:  Nanomaterials (Basel)       Date:  2022-09-24       Impact factor: 5.719

5.  Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.

Authors:  Xiangtian Deng; Renliang Zhao; Qingcheng Song; Yiran Zhang; Haiyue Zhao; Hongzhi Hu; Zhen Zhang; Weijian Liu; Wei Lin; Guanglin Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.